GKSD Investment Holding SA Statement regarding NMC Health plc (4900F)
09 Marzo 2020 - 10:18AM
UK Regulatory
TIDMNMC
RNS Number : 4900F
GKSD Investment Holding SA
09 March 2020
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AND IS NOT FOR
RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR
INTO OR FROM, ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A
VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.
THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE
ON TAKEOVERS AND MERGERS (THE "CODE").
FOR IMMEDIATE RELEASE
Statement from GKSD Investment Holding SA ("GKSD"),
a company backed by sponsors of Gruppo San Donato ("GSD")
No intention to offer for NMC Health plc ("NMC")
Further to the announcements by GKSD dated 11 February 2020 and
NMC dated 10 February 2020, GKSD announces that it does not intend
to make a firm offer for NMC.
Gruppo San Donato is one of the largest hospital groups in
Europe with approx. 17,000 employees offering clinical excellence
to approx. 5 million patients per year. GSD is also the principal
centre for medical research in Italy. GSD will maintain its offer
of operational support to NMC to assist the NMC business in its
continued delivery of a high standard of healthcare in the EMEA
region.
As a result of this announcement, GKSD and any person(s) acting
in concert with it will be bound by the restrictions contained in
Rule 2.8 of the Code.
For the purposes of Rule 2.8 of the Code, GKSD, and any
person(s) acting in concert with it reserves the right to make or
participate in an offer or possible offer for NMC (and/or take any
other action which would otherwise be restricted under Rule 2.8 of
the Code) within 6 months following the date of this
announcement:
(i) with the agreement of the Board of NMC;
(ii) following the announcement of a firm intention to make an
offer for NMC by a third party;
(iii) following the announcement by NMC of a "whitewash"
proposal (for the purposes of Note 1 on the Notes on Dispensations
from Rule 9 of the Code) or a reverse takeover; or
(iv) if the Panel on Takeovers and Mergers determines that there
has been a material change of circumstances.
Enquiries
Rothschild & Co +44 207 280 5000
Hedley Goldberg
Thibault Poirier
Goldman Sachs International +44 20 7774 1000
Ben Thorpe
Chris Emmerson
Morgan Stanley +44 20 7425 8000
Matthew Jarman
Duncan Williamson
Important Notices
N.M. Rothschild & Sons Limited ("Rothschild & Co"),
which is authorised and regulated by the Financial Conduct
Authority in the United Kingdom, is acting as financial adviser for
GKSD and for no one else in connection with the subject matter of
this announcement and will not be responsible to anyone other than
GKSD for providing the protections afforded to its clients or for
providing advice in connection with the subject matter of this
announcement.
Goldman Sachs International, which is authorised by the
Prudential Regulation Authority ("PRA") and regulated by the PRA
and the Financial Conduct Authority ("FCA") in the United Kingdom,
is acting exclusively for GKSD and for no one else in connection
with the possible offer and will not be responsible to anyone other
than GKSD for providing the protections afforded to its clients or
for providing advice in relation to the possible offer, the
contents of this announcement or any other matters referred to in
this announcement.
Morgan Stanley & Co. International plc ("Morgan Stanley")
which is authorised by the Prudential Regulation Authority and
regulated by the Financial Conduct Authority and the Prudential
Regulation Authority in the UK is acting as financial adviser
exclusively for GKSD and no one else in connection with the matters
set out in this announcement. In connection with such matters,
Morgan Stanley, its affiliates and their respective directors,
officers, employees and agents will not regard any other person as
their client, nor will they be responsible to any other person for
providing the protections afforded to their clients or for
providing advice in connection with the contents of this
announcement or any other matter referred to herein.
MAR
The information contained within this announcement is considered
by GKSD to constitute inside information as stipulated under the
Market Abuse Regulations (EU) No.596/2014 ("MAR"). Upon the
publication of this announcement via a Regulatory Information
Service, this inside information will be considered to be in the
public domain.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
OFDFLFLRVVIAIII
(END) Dow Jones Newswires
March 09, 2020 12:18 ET (16:18 GMT)
Nmc Health (LSE:NMC)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Nmc Health (LSE:NMC)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024